Keiji Yokoyama

4PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Sport and exercise nutritionCancer diagnosisImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 23, 2022
Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites.

Keiji Yokoyama, Hiromi Fukuda, Ryo Yamauchi

|Sep 06, 2022
A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus-related decompensated cirrhosis.

Tomoya Sano, Keisuke Amano, Tatsuya Ide

|Dec 28, 2020
Hepatitis B virus core-related antigen is useful for surveillance of hepatocellular carcinoma recurrence in a patient with occult hepatitis B virus infection: Case report.

Keiji Yokoyama, Eri Yamauchi, Yotaro Uchida

|Sep 14, 2020
Irsogladine maleate alters expression of a tight junction protein in portal hypertensive gastropathy.

Keiji Yokoyama, Makoto Irie, Naoaki Tsuchiya

Pageof 1

Frequent Collaborators

3 joint publications

Kazuhide Takata

2 joint publications

Fumihito Hirai

2 joint publications

Ryo Yamauchi

1 joint publications

Daisuke Morihara